Blood Cells Molecules and Diseases

Papers
(The median citation count of Blood Cells Molecules and Diseases is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Hereditary disorders of ineffective erythropoiesis31
ABO blood groups, COVID-19 infection and mortality30
Clinical characteristics, laboratory features and genetic profile of hemoglobin E (HBB:c.79 G > A)/β (nucleotide -28 A > G) (HBB:c.-78 A > G) -thalassemia subjects identified from community- 27
Platelet counts on peripheral blood and Mean Platelet Volume as markers of clinical severity in Sickle Cell Disease25
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort23
Effect of voxelotor on murine bone marrow and peripheral blood with hematopoietic progenitor cell mobilization for gene therapy of sickle cell disease18
Platelet activation and blood extracellular vesicles: The influence of venepuncture and short blood storage16
TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia14
Investigation on abnormal gene loci of a Chinese pedigree with hereditary combined deficiency of blood coagulation factor XI, XII, and protein S12
Acquired elliptocytosis in chronic myeloid neoplasms: An enigmatic relationship to acquired red cell membrane protein and genetic abnormalities11
Immunological profile in a pediatric population of patients with spherocytosis. A single-center experience10
Molecular mechanisms underlying the role of HLA-DQ in systemic immune activation in severe aplastic anemia10
Editorial Board10
Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment10
The inhibitor of MyoD Family A (I-MFA) regulates megakaryocyte lineage commitment and terminal differentiation9
Effectiveness of convalescent plasma in Indian patients with COVID-199
Neoplastic bone marrow invasion:rapid exclusion of hematological disease by flow cytometric routine panels9
Aberrant baseline cytokine profile in patients with newly diagnosed acquired aplastic anaemia correlates with disease severity and the treatment response9
The utility of multiple genomic technologies for interpretation of modern next generation sequencing: A novel case of three FANCA gene variants resulting in autosomal recessive Fanconi anaemia9
Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monother9
Targeting of Calbindin 1 rescues erythropoiesis in a human model of Diamond Blackfan anemia8
Characterisation of a mitochondrial glutamine transporter provides a new opportunity for targeting glutamine metabolism in acute myeloid leukaemia8
Surgical procedures and complications in placement of totally implantable venous access port in pediatric hemophilia patients: A retrospective analysis8
Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India8
High-throughput methods for the analysis of transcription factors and chromatin modifications: Low input, single cell and spatial genomic technologies7
Investigation of the cytotoxicity, genotoxicity and antioxidant prospects of JM-20 on human blood cells: A multi-target compound with potential therapeutic applications7
Pilot assessment of omega-3 fatty acids and potassium thiocyanate in sickle cell anemia patients with conditional peak systolic cerebral artery blood velocity7
The 50th anniversary of Blood Cells, Molecules and Diseases, 1975–20246
Prognostic factors associated with COVID-19 related severity in sickle cell disease6
The role of PKC in X-ray-induced megakaryocyte apoptosis and thrombocytopenia6
Pancytopenia and thrombosis defects in zebrafish mutants of Fanconi anemia genes6
Essential genetic modifiers and their measurable impact in a community-recruited population analysis for non-severe hemoglobin E/β-thalassemia prenatal genetic counseling6
Red cell distribution width as a bellwether of prognosis6
Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease6
Erythrocyte deformability correlates with systemic inflammation6
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?5
Comprehensive analysis of sickle β+-thalassemia genotypes and their associated HbA levels in France5
Marked microcytosis and increased transferrin saturation: Think about variants in SLC11A2 (DMT1)5
First report of a patient with homozygous hemoglobin Ernz: Evidence to support a non-pathogenic variant5
Corrigendum to “Outpatient ATG-free hematopoietic transplantation for severe aplastic anemia in limited-resource environments offers excellent results: Data from a single LATAM center” [Blood Cells, M5
Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response5
Co-morbidities and mortality in patients with sickle cell disease in England: A 10-year cohort analysis using hospital episodes statistics (HES) data5
Corrigendum to “Clinical utility of relative telomere length analysis in pediatric bone marrow failure” [Blood Cells Mol. Dis. 109 (2024) 102882]5
Sickle cell disease in Indian tribal population: Findings of a multi-centre Indian SCD registry5
Editorial Board4
Growth hormone is involved in GATA1 gene expression via STAT5B in human erythroleukemia and monocytic cell lines4
Commentary on “unmasking the morphological alteration of erythrocytes among women suffering from PCOS”4
Editorial Board4
The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patients4
Editorial Board4
Editorial Board4
Editorial Board4
Thirty-five males with severe (Class 1) G6PD deficiency (c.637G>T) in a North American family of European ancestry3
Trpv1 and Trpa1 are not essential for Psickle-like activity in red cells of the SAD mouse model of sickle cell disease3
Phenotypic and genotypic evaluation of bleeding diagnostic dilemmas: Two case studies3
Editorial Board3
Loss of ZNF215 imprinting is associated with poor five-year survival in patients with cytogenetically abnormal-acute myeloid leukemia3
Response to commentary on “Unmasking the morphological alteration of erythrocytes among women suffering from PCOS”3
Malignant histiocytosis with a Langerhans cell subtype: A report on the diagnostic and therapeutic challenge3
Extreme γ′ fibrinogen levels in COVID-19 patients3
Identification of Nfel1a and Nfel3 as novel regulators for zebrafish thrombopoiesis3
Daucosterol regulates JAK2-STAT3 signaling pathway to promote megakaryocyte differentiation3
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A−c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations2
Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute2
Editorial Board2
Characterization of peripheral blood T follicular helper (TFH) cells in patients with type 1 Gaucher disease and carriers2
Letter to editor: Authorship of biomedical science papers2
Editorial Board2
Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients2
Plasma exosomal microRNA expression profiles in patients with high-altitude polycythemia2
Danazol causes significant changes in the cardiometabolic profile of patients with acquired aplastic anaemia2
γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity2
Rare bleeding disorders: Real-world data from a Spanish tertiary hospital2
VCAM1, HMOX1 and NOS3 differential endothelial expression may impact sickle cell anemia vasculopathy2
Diagnostic challenges posed by a rare unstable hemoglobin variant Hb Southampton [HBB: c.320T → C] with pyrimidine 5′ nucleotidase deficiency and the response to HU therapy2
Editorial Board2
Missense mutation in RPS7 causes Diamond-Blackfan anemia via alteration of erythrocyte metabolism, protein translation and induction of ribosomal stress2
Inherited disorders of hemoglobin: A review of old and new diagnostic methods2
Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)2
Editorial Board2
Editorial Board2
Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination2
Molecular characterization of a novel 83.9-kb deletion of the α-globin upstream regulatory elements by long-read sequencing2
Unmasking the morphological alteration of erythrocytes among women suffering from PCOS2
Analysis of baseline characteristics, disease burden and long-term follow-up of 167 patients with Paroxysmal Nocturnal Hemoglobinuria at a single center in Brazil2
Accelerated phase development in a late-onset adolescent Chediak-Higashi syndrome patient caused by compound novel LYST mutations in the setting of SARS-CoV-2 infection1
Expression of gilt acts as a positive regulator of mouse hematopoietic progenitor cells1
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis1
Comparative Analysis of the Genetic Variants in Haematopoietic Stem/Progenitor and Mesenchymal Stem Cell Compartments in de novo Myelodysplastic Syndromes1
Preclusion of methemoglobinemia caused by nitrate drugs in diabetics and nondiabetics: Possible role of Vitamin C1
Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients1
Editorial Board1
Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease1
Diamond-Blackfan anemia, the archetype of ribosomopathy: How distinct is it from the other constitutional ribosomopathies?1
PKLR mutations in pyruvate kinase deficient Polish patients: Functional characteristics of c.101-1G > A and c.1058delAAG variants1
Short- and long-term alterations of hematopoietic cell lineages in rats with congenital iron deficiency1
Two new mutations in the GLRX5 gene cause sideroblastic anemia1
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort1
Megakaryocyte-specific knockout of the Mir-99b/let7e/125a cluster lowers platelet count without altering platelet function1
Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore1
Hypoferremia of inflammation: Innate host defense against infections1
Calcium flux alterations in erythrocytes from sickle cell mice: The relevance of mean corpuscular volume1
Characterization of peripheral T helper 17 (Th17) cells phenotype in postmenopausal women with estrogen insufficiency1
Hematologically important mutations: Leukocyte adhesion deficiency (second update)1
Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemia1
New germline GATA1 variant in females with anemia and thrombocytopenia1
Development of a Thalassemia International Prognostic Scoring System (TIPSS)1
Whole exome sequencing of a breast tumor in a patient with Diamond Blackfan anemia1
Mouse models of sickle cell disease: Imperfect and yet very informative1
0.10659408569336